Global Pneumococcal Vaccine Market Data Survey Report 2025
- HEY1541399
- 76 Pages
- August 2017
- Pharmaceuticals
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
The global Pneumococcal Vaccine market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
MSD
Sanofipasteur
CDIBP
Pfizer
GSK
Major applications as follows:
Infants
Children (2-10)
Person (10-64)
The old (?65)
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 MSD
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Sanofipasteur
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 CDIBP
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Pfizer
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 GSK
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Infants
4.1.1 Overview
4.1.2 Infants Market Size and Forecast
4.2 Children (2-10)
4.2.1 Overview
4.2.2 Children (2-10) Market Size and Forecast
4.3 Person (10-64)
4.3.1 Overview
4.3.2 Person (10-64) Market Size and Forecast
4.4 The old (?65)
4.4.1 Overview
4.4.2 The old (?65) Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of MSD
Tab Sales Revenue, Volume, Price, Cost and Margin of Sanofipasteur
Tab Sales Revenue, Volume, Price, Cost and Margin of CDIBP
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Pneumococcal Vaccine Market Size and CAGR 2011-2017 (Value)
Fig Global Pneumococcal Vaccine Market Size and CAGR 2011-2017 (Volume)
Fig Global Pneumococcal Vaccine Market Forecast and CAGR 2018-2025 (Value)
Fig Global Pneumococcal Vaccine Market Forecast and CAGR 2018-2025 (Volume)
Fig Infants Market Size and CAGR 2011-2017 (Value)
Fig Infants Market Size and CAGR 2011-2017 (Volume)
Fig Infants Market Forecast and CAGR 2018-2025 (Value)
Fig Infants Market Forecast and CAGR 2018-2025 (Volume)
Fig Children (2-10) Market Size and CAGR 2011-2017 (Value)
Fig Children (2-10) Market Size and CAGR 2011-2017 (Volume)
Fig Children (2-10) Market Forecast and CAGR 2018-2025 (Value)
Fig Children (2-10) Market Forecast and CAGR 2018-2025 (Volume)
Fig Person (10-64) Market Size and CAGR 2011-2017 (Value)
Fig Person (10-64) Market Size and CAGR 2011-2017 (Volume)
Fig Person (10-64) Market Forecast and CAGR 2018-2025 (Value)
Fig Person (10-64) Market Forecast and CAGR 2018-2025 (Volume)
Fig The old (?65) Market Size and CAGR 2011-2017 (Value)
Fig The old (?65) Market Size and CAGR 2011-2017 (Volume)
Fig The old (?65) Market Forecast and CAGR 2018-2025 (Value)
Fig The old (?65) Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
